What is a clinical pipeline?

A drug pipeline is the set of drug candidates that an individual pharmaceutical company or the entire pharmaceutical industry collectively has under discovery or development at any given point in time. The drug pipeline is an important indicator of the value and future prospects of a company.

What are pipeline therapies?

A research “pipeline” is the process of creating, testing, and ultimately approving a new drug for use in humans. HDSA funds researchers and doctors doing HD research at different stages along the pipeline, and collaborates with industry partners to bring information about clinical trials to the public.

How long does the pharmaceutical development pipeline take?

The discovery and development of new medicines is a long, complex and rigorous process. Every step is aimed at bringing effective medicines to patients as quickly as possible, while ensuring the highest possible level of safety. It takes an average of ten years to develop a potential new medicine.

What do clinical development do?

Clinical Development, also called Drug Development, is a blanket term used to define the entire process of bringing a new drug or device to the market. It includes drug discovery / product development, pre-clinical research (microorganisms/animals) and clinical trials (on humans).

How are antibacterial drugs in the clinical pipeline?

The clinical pipeline part of the report assesses antibacterial drug candidates in clinical development stages worldwide, including direct-acting small molecules, biological agents, and for the first time non-traditional antibacterial medicines in the pipeline.

What is in Merck’s late stage clinical development pipeline?

Updated May 5, 2021. Our pipeline provides an overview of our late-stage clinical development programs and is updated quarterly. V114 is an investigational vaccine currently being evaluated for its ability to provide protection against pneumococcal disease caused by serotypes contained in the vaccine. 1 – Being developed in collaboration.

What do you need to know about Novartis cancer pipeline?

At Novartis, our portfolio and clinical trials are built around patient needs in key cancer areas. Explore our pipeline and resources. View our broad research portfolio with investigational compounds in all phases of development. All compounds are either investigational or being studied for (a) new use (s).

What is the state of the drug pipeline?

This study examines the state of the drug pipeline and provides insights into such areas as the therapeutic areas being explored, the distribution of clinical research projects by phase, the number of potential first- in-class medicines, and some of the new areas of scientific opportunity being applied to advance treatments.